ATE254455T1 - Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel - Google Patents

Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Info

Publication number
ATE254455T1
ATE254455T1 AT99951559T AT99951559T ATE254455T1 AT E254455 T1 ATE254455 T1 AT E254455T1 AT 99951559 T AT99951559 T AT 99951559T AT 99951559 T AT99951559 T AT 99951559T AT E254455 T1 ATE254455 T1 AT E254455T1
Authority
AT
Austria
Prior art keywords
water
mixable
pharmaceutical compositions
compositions containing
containing paclitaxel
Prior art date
Application number
AT99951559T
Other languages
English (en)
Inventor
Joseph Rubinfeld
Rajashree Joshi
Ashok Y Gore
Rajesh Shrotriya
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Application granted granted Critical
Publication of ATE254455T1 publication Critical patent/ATE254455T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99951559T 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel ATE254455T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/183,199 US6017948A (en) 1998-10-30 1998-10-30 Water-miscible pharmaceutical compositions
PCT/US1999/021990 WO2000025775A1 (en) 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel

Publications (1)

Publication Number Publication Date
ATE254455T1 true ATE254455T1 (de) 2003-12-15

Family

ID=22671864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951559T ATE254455T1 (de) 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Country Status (11)

Country Link
US (1) US6017948A (de)
EP (1) EP1124549B1 (de)
JP (1) JP2002528494A (de)
CN (1) CN1178655C (de)
AT (1) ATE254455T1 (de)
AU (1) AU775158B2 (de)
CA (1) CA2345697A1 (de)
DE (1) DE69912983D1 (de)
IL (1) IL142720A (de)
MX (1) MXPA01004268A (de)
WO (1) WO2000025775A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
EP1418945A2 (de) * 2001-03-13 2004-05-19 Angiotech Pharmaceuticals, Inc. Mizellare arzneimittelabgabe vehikel und ihre anwendungen
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
JP2004532847A (ja) 2001-04-20 2004-10-28 ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア 疎水性薬物のためのミセル薬物送達システム
US20030126788A1 (en) * 2001-11-07 2003-07-10 Colloid Tech. Inc. Storage stable translucent flammable article
WO2003047508A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Paclitaxel solvates
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
PL206379B1 (pl) * 2002-07-15 2010-08-31 Alcon Ulegająca bioerozji kompozycja do wytwarzania błony do dostarczania leków oftalmicznych i zastosowanie
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
ZA200800314B (en) 2005-06-29 2009-09-30 Threshold Pharmaceuticals Inc Phosphoramidate alkylator prodrugs
US9943490B2 (en) * 2007-11-05 2018-04-17 The Trustees Of Princeton University Composite flash-precipitated nanoparticles
PL2231144T3 (pl) * 2007-12-24 2014-12-31 Sun Pharma Advanced Res Co Ltd Nanodyspersja
WO2010048330A1 (en) * 2008-10-21 2010-04-29 Threshold Pharmaceuticals, Inc. Treatment of cancer using hypoxia activated prodrugs
US8778364B2 (en) 2009-06-19 2014-07-15 Sun Pharma Advanced Research Company Ltd. Nanodispersion of a drug and process for its preparation
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
US20120172796A1 (en) * 2010-12-30 2012-07-05 Chappa Ralph A Composition for intravascular delivery of therapeutic composition
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN112972419B (zh) * 2019-12-02 2024-03-08 四川科伦药物研究院有限公司 一种白蛋白纳米药物组合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5034397A (en) * 1985-12-12 1991-07-23 Bristol-Myers Squibb Co. Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
JP2963537B2 (ja) * 1989-05-26 1999-10-18 アボツト・ラボラトリーズ クラリトロマイシンの注射用組成物
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE69507493T2 (de) * 1994-09-01 1999-06-10 Upjohn Co Tirilazad parentale formulierung mit einem co-lösungsmittel
AU4652596A (en) * 1995-01-09 1996-07-31 Atrix Laboratories, Inc. Liquid polymer delivery system
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
CZ293747B6 (cs) * 1995-12-21 2004-07-14 Pfizer Inc. Vodný farmaceutický roztok vhodný pro injekční podávání hostiteli a jeho použití
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel

Also Published As

Publication number Publication date
MXPA01004268A (es) 2002-06-04
WO2000025775A1 (en) 2000-05-11
EP1124549B1 (de) 2003-11-19
IL142720A0 (en) 2002-03-10
AU6397799A (en) 2000-05-22
JP2002528494A (ja) 2002-09-03
AU775158B2 (en) 2004-07-22
DE69912983D1 (de) 2003-12-24
CN1368880A (zh) 2002-09-11
EP1124549A1 (de) 2001-08-22
US6017948A (en) 2000-01-25
CA2345697A1 (en) 2000-05-11
IL142720A (en) 2005-03-20
CN1178655C (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
DE69912983D1 (de) Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel
DE50004352D1 (de) Farbmittelzubereitungen
BR0215405A (pt) Composições e processos de uso de collajolie
ITRM20020411A1 (it) Derivati dello spirobifluorene, loro preparazione e loro uso.
BR9915515B1 (pt) composiÇço curÁvel de multicomponentes.
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
WO2004045001A3 (en) Organic light emitting materials and devices
AU2001274078A1 (en) Prepolymeric (meth)acrylates with polycyclic or aromatic segments
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
NO20012739L (no) 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer
NO20003930L (no) Sammensetninger som inneholder organiske forbindelser
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
BR0300500B1 (pt) composiÇço poliolefÍnica, processo para estabilizaÇço de uma poliolefina e uso de uma mistura.
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
NO20032252D0 (no) Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor
DE59903442D1 (de) Azidfreie, gaserzeugende Zusammensetzung
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
AR028162A1 (es) Disponibilidad controlada de compuestos de formulacion, composiciones y metodos para el lavado que utilizan los mismos.
ES2126545T1 (es) Monomeros de epoxido reactivos curables cationicamente iniciados termicamente o por radiacion, y composiciones realizadas a partir de estos monomeros.
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
PA8577701A1 (es) Polipeptido t20 pegilado
BR0007922A (pt) Compostos calcilìticos
ATE441626T1 (de) Azeotropähnliche zusammensetzungen und deren verwendung
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties